| REPLIGEN CORP. DL-,01 |
| USA |
| Gesundheit |
| US7599161095 / 870980 |
| RGN (Frankfurt) / RGEN (NASDAQ) |
| FRA:RGN, ETR:RGN, RGN:GR, NASDAQ:RGEN |
| - |
| http://www.repligen.com/ |
|
Repligen Corporation is a leading global provider ..
>Volltext.. |
| 7751.11 Mio. EUR |
| 7700.1 Mio. EUR |
| 602.96 Mio. EUR |
| 145.58 Mio. EUR |
| 1.48 Mio. EUR |
| 0.02 EUR |
| 586.76 Mio. EUR |
| 637.76 Mio. EUR |
| 111.49 Mio. EUR |
| 5.71 |
| 6.02% |
| - |
| - |
| - |
| - |
| REPLIGEN |
| 17.12.25 |
|